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Pseudoangiomatousstromal hyperplasia (PASH) is a rare benign proliferating breast condition.It was ﬁrst reported in 1986 when
Vuitch, Rosen, and Erlandson described nine cases of benign well-circumscribed, breast masses that simulated vascular lesions
consistingofmammary stromalproliferations (Vuitch et al. (1986)).Since then there have been few reported cases of PASH in the
literature (Taira et al. (2005)). We describe a large PASH, mimicking inﬂammatory carcinoma in a young lady that was excised
with excellent cosmetic results.
1.CaseReport
A 22-year-old lady presented to the breast clinic with a one-
year history of a lump in the right breast. The lump progres-
sively increased in size until there was a marked diﬀerence
between bothbreasts. On clinicalassessment, theright breast
was diﬀusely erythematous with prominent superﬁcial veins
and skin changes. The palpable mass was around 10 × 8cm
in diameter and felt clinically suspicious of malignancy
mimicking inﬂammatory carcinoma (Figure 1). Ultrasound
scan showed a 10 × 5cm mass consistent with ﬁbroadenoma
or Phyllodes tumour, while MRI showed a 10cm well-
circumscribed rounded mass lesion which demonstrated a
benign enhancement pattern after intravenous Gadolinium.
Radiologicallytheappearancesremainedmostsuggestiveofa
ﬁbroadenoma or Phyllodes tumour, but also in keeping with
PASH (Figure 2).
Fine needle aspiration cytology results were equivocal
showing cohesive cells with focal mild nuclear atypia and
numerous bare nuclei. Core biopsy was done that showed
the presence of spindle cells in the ﬁbrous tissue in a
pseudoangiomatous pattern which ﬁtted the diagnosis of
PASH. This was the same ﬁnding on the ﬁnal histopathology
after excision (Figure 3). Immunohistochemistry was posi-
tive for CD34 and Vimentin while Factor VIII, cytokeratin,
progesterone, and oestrogen receptors were negative.
Surgical excision was done using an inferior circumareo-
lar incision. The mass was excised through a small incision,
and the breast with simple glandular remodelling the patient
hadexcellentcosmeticresultspostoperatively(Figure 4).The
patient has been followed up for 18 months now without
evidence of recurrence.
2.Discussion
PASH is a benign proliferation of the mammary stromal
tissue. Histologically it shows complex interanastomosing
slit-like spaces which appear to be lined by spindle cells in
thebreastparenchyma [1].This isnotan uncommonﬁnding
in both benign and malignant breast specimens with up to
23% of the specimens showing small foci of PASH [2]. It is,
however, rare for a discrete mass to have PASH as the main
pathological feature on histopathology with only around a
hundred cases reported in the literature.
These tumours are classiﬁed into either simple or
fascicular/proliferative subtypes. In the simple type open,2 Case Reports in Medicine
Figure 1: Figure demonstrating the asymmetry and the large mass
in the right breast on presentation.
Figure 2: MRI showing the 10cm well-circumscribed rounded
mass lesion which demonstrated a benign enhancement pattern
after intravenous Gadolinium.
slit-like anastomosing channels without erythrocytes appear
to be lined by ﬂat cells in a discontinuous layer while in
the fascicular/proliferative type there are areas of cellular
proliferation composed of bland spindle cells. One paper
describes gynaecomastia-like changes in nearly two thirds
of the cases [3]. It is important to diﬀerentiate the lesion
from low-grade angiosarcoma. PASH does not exhibit any
atypia or mitotic activity, and there are no blood cells seen
in the slit-like structures [4]. Cytology is nonspeciﬁc and it
is impossible to diagnose on ﬁne needle aspiration cytology.
Core biopsy or Mammotome biopsy is needed for diagnosis
preoperatively, although in some cases the ﬁnal diagnosis
is made only after excision [4]. On immunohistochemistry,
PASH is positive for CD34 and vimentin and negative for
factor VIII-related antigen and cytokeratin [3–5].
On radiology there are no speciﬁc or diagnostic features.
Mostofthesetumoursmimic ﬁbroadenomasorhamartomas
though other sinister pathologies such as angiosarcomas
come into the diﬀerential diagnosis and larger tumours can
be mistaken for Phyllodes tumour [3, 6, 7]. On mammog-
raphy the commonest ﬁnding is a well-deﬁned mass while
ultrasound scan shows usually a hypoechoic discrete mass
withbenign features[8, 9]t h o u ghs o m eh a v ed e s c ri b e dc a s e s
(a)
(b)
Figure 3: (a) Anastomosing groups of spindle cells in the stroma.
Normal breast epithelium top left. (b) Stromal spindle cells which
appear to be lining slit-like spaces devoid of red blood cells.
where the mass was either spiculated, irregular or had ill-
deﬁned margins on radiology [3, 6].
The aetiology of this is not well understood though
some authors have suggested a hormonal cause of this
condition [1, 4, 10]. Many of the patients diagnosed are
premenopausal, and there is association with the use of
hormones for contraception or as hormonal replacement
therapy [3, 10]. Many have reported positive progesterone
receptor status in those lesions which further supports this
theory but our case was negative for both oestrogen and
progesteron receptors [4, 5]. Pruthi et al. reported treating
one patient with Tamoxifen with good results [11].
I fdiagn os isisc on ﬁ rm edonbiops yan dth eles ioniss m all
and asymptomatic, then surgical excision can be avoided but
for the larger lesions, and especially if there are suspicious
features clinically or radiologically, then surgical excision is
indicated [3, 4]. While most will perform an excision biopsy
to conﬁrm the diagnosis ad get clear margins, some have
performed mastectomies especially for the larger lesions. In
our report, though the lesion was large, it was still all excised
through as small circumareolar incision. Symmetrisation
procedure was considered for this particular case because of
the size diﬀerence before excising the lesion, but following
the excision the patient was happy with the cosmetic result
as the size and shape of the operated breast was reported to
be back to normal as before the PASH appeared.Case Reports in Medicine 3
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Figure4:((a),(b),and(c))Intraoperativepictures.(d)Postoperativepictures showthegoodcosmeticresultswithslightasymmetrybetween
both sides, reported by the patient as being her normalas before the PASH appeared.
PASH is a rare benign condition that is diagnosed on
triple assessment. If it is proven on biopsy, then regular
followup is suitable. Surgery is reserved for people with large
lesions or if the histology did not conﬁrm the diagnosis
preoperativelyand ifthereisany suspiciousfeaturesontriple
assessment orpatients choice. Followup following excision is
recommended as local recurrence has been reported.
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